Whitepaper: Straight to Market in an Autoinjector: A Smart, Data-Driven Approach to Formulate Biotherapeutics for Pre-filled Syringes with Confidence

The global prefilled syringe (PFS) market was estimated at $7.22 billion in 2022 and is forecast to grow to $16.32 billion by 2030. The use of PFSs to administer biotherapeutics is beginning to gain traction because they offer a range of stability, efficacy, and patient safety benefits. Lonza has used advanced testing capabilities to assess the factors that could impact injection force and developed a novel workflow to ensure confidence regarding functionality in PFS and autoinjectors.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.


  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the phone number you would like to be contacted at.

  • Please enter the e-mail address you would like to be contacted at.


    • By submitting this form, you consent to Pharmaceutical Outsourcing storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.